迪克洛芬雅克使多种药物耐药的Acinetobacter baumannii对胆固醇素敏感
bioRxiv : the preprint server for biology
|May 27, 2024
概括
迪克洛菲纳克可以使多药耐药 (MDR) 菌对最后的抗生素 - - 胆固醇素重新敏感. 这种组合疗法通过减少细菌毒性因子,显示出治疗困难感染的前景.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 多种药物耐药 (MDR) Acinetobacter baumannii构成了严重的全球健康威胁,需要新的治疗策略.
- 胆固醇是对抗卡巴耐药A. baumannii的最后避险抗生素,但耐药性正在出现.
- 非类固醇抗炎药Diclofenac已经显示出对抗耐药细菌的潜力.
结论:
- 降低类型IV pili的调节对于胆固醇和二二的协同抗感染活性至关重要.
- 这种组合表现出抗病毒效应,为对抗MDR A. baumannii提供了潜在的策略.
- 用胆固醇重新定位迪克洛芬雅克是一种有希望的方法来治疗具有挑战性的MDR细菌感染.
更多相关视频
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
584
07:16Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
988
相关概念视频
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Antibiotic Selection
53.2K
Overview
53.2K
